Rufiga Shari Abidin: Multi Organ Complications Detailed in COVID 19 Vaccine Adverse Event Study
Rufiga Shari Abidin, Lecturer at Hasanuddin University, shared a post on LinkedIn:
“This paper lists adverse events caused by COVID-19 vaccines across multiple organs with examples of cases.
Adverse events described include myopericarditis, thrombocytopenia, anemia, cerebral venous sinus thrombosis, leukocytoclastic vasculitis, chiblain-like lesions, herpes zoster, pityriasis rosea, immunoglobulin nephropathy, tubulointerstitial nephritis, acute disseminated encephalomyelitis, hyponatremia, memory loss, idiopathic facial paralysis and rhabdomyolysis.
The iteration that ‘the number of adverse events are relatively low’ and that ‘vaccination benefits still outweigh the risks’, appears as something the authors and authors of other papers have to swallow and repeat in order to be able to share their data and findings, where content and data are hinting the contrary.
Even just one adverse events presented in this paper should have put a stop to the clinical trials, stop vaccine roll-out to the public, and led to the COVID-19 vaccine withdrawal from the market.
The vaccine injured should not just be reduced to numbers and represented in an underestimated statistical calculations.”
Title: Review of adverse events associated with COVID-19 vaccines, highlighting their frequencies and reported cases
Authors: Harshini Yaamika, Divya Muralidas, Karthikeyan Elumalai
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery